LGT Fund Management Co Ltd. Buys Shares of 9,230 Xylem Inc. (NYSE:XYL)

LGT Fund Management Co Ltd. bought a new stake in Xylem Inc. (NYSE:XYLFree Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 9,230 shares of the industrial products company’s stock, valued at approximately $1,055,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Morgan Stanley boosted its position in shares of Xylem by 11.5% during the third quarter. Morgan Stanley now owns 4,528,905 shares of the industrial products company’s stock worth $412,267,000 after buying an additional 466,911 shares during the period. Invesco Ltd. boosted its position in shares of Xylem by 35.1% during the third quarter. Invesco Ltd. now owns 4,182,821 shares of the industrial products company’s stock worth $380,762,000 after buying an additional 1,086,102 shares during the period. Royal Bank of Canada boosted its position in shares of Xylem by 10.6% during the third quarter. Royal Bank of Canada now owns 3,408,200 shares of the industrial products company’s stock worth $310,249,000 after buying an additional 327,383 shares during the period. Baillie Gifford & Co. boosted its position in shares of Xylem by 2.3% during the fourth quarter. Baillie Gifford & Co. now owns 3,066,639 shares of the industrial products company’s stock worth $350,701,000 after buying an additional 69,619 shares during the period. Finally, Northern Trust Corp boosted its position in shares of Xylem by 4.0% during the third quarter. Northern Trust Corp now owns 2,617,441 shares of the industrial products company’s stock worth $238,266,000 after buying an additional 100,728 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Price Performance

Shares of NYSE XYL traded up $4.50 during trading on Thursday, hitting $135.46. The company had a trading volume of 1,043,182 shares, compared to its average volume of 1,162,412. The company has a market cap of $32.84 billion, a P/E ratio of 48.15, a PEG ratio of 2.60 and a beta of 1.08. Xylem Inc. has a 52 week low of $87.59 and a 52 week high of $137.18. The business’s 50-day moving average is $128.19 and its 200 day moving average is $114.74. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.30 and a current ratio of 1.76.

Xylem (NYSE:XYLGet Free Report) last announced its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.06. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The company had revenue of $2.03 billion for the quarter, compared to the consensus estimate of $2 billion. During the same period in the previous year, the business earned $0.72 EPS. The company’s revenue was up 40.4% on a year-over-year basis. Equities research analysts predict that Xylem Inc. will post 4.13 earnings per share for the current fiscal year.

Xylem Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were paid a dividend of $0.36 per share. This is an increase from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a yield of 1.06%. The ex-dividend date was Tuesday, February 20th. Xylem’s payout ratio is 52.94%.

Wall Street Analysts Forecast Growth

XYL has been the subject of several analyst reports. Robert W. Baird boosted their price objective on Xylem from $141.00 to $148.00 and gave the stock an “outperform” rating in a research report on Thursday, March 21st. BNP Paribas assumed coverage on Xylem in a research report on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 target price for the company. Royal Bank of Canada upped their target price on Xylem from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 7th. Citigroup upped their target price on Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research report on Monday, April 8th. Finally, Oppenheimer upped their target price on Xylem from $133.00 to $142.00 and gave the stock an “outperform” rating in a research report on Thursday, April 18th. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, Xylem presently has an average rating of “Moderate Buy” and an average price target of $138.11.

Get Our Latest Stock Report on XYL

Insider Buying and Selling at Xylem

In other news, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at $360,682.15. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.